Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H2CS
|
|||
| Former ID |
DNC002884
|
|||
| Drug Name |
Glycinamid
|
|||
| Synonyms |
Glycinamide; 2-Aminoacetamide; 598-41-4; Glycine amide; Acetamide, 2-amino-; GLYCINAMID; AMINOMETHYLAMIDE; 2-Amino-Acetamide; CHEBI:42843; BEBCJVAWIBVWNZ-UHFFFAOYSA-N; Glycinamide HCl; AI3-60342; aminoacetamide; glycineamide; glycinamidehcl; glycine-amide; glycine imine; Glycinimidic acid; alpha-aminoacetamide; EINECS 209-932-4; GlyNH2; 2-Aminoacetamide #; Gly-NH2; Glycineamide, G-NH2; AC1L2AXY; H2NCH2CONH2; Glycine amide hydrobromide; AC1Q53MT; CHEMBL86954; 598-41-4 (Parent); DTXSID1060508; 1668-10-6 (hydrochloride); CTK1H1328; CTK1D7741
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C2H6N2O
|
|||
| Canonical SMILES |
C(C(=O)N)N
|
|||
| InChI |
1S/C2H6N2O/c3-1-2(4)5/h1,3H2,(H2,4,5)
|
|||
| InChIKey |
BEBCJVAWIBVWNZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 598-41-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
829364, 3726729, 6884172, 7887928, 8192534, 10528984, 11109885, 14747325, 24770334, 24770341, 26697251, 32613263, 37634556, 38333938, 43125522, 46506909, 50840202, 57317197, 85164350, 97857504, 99218065, 103034513, 103296323, 104233958, 104343699, 117530471, 119503230, 123059453, 123059835, 123121006, 125748603, 126607288, 126644433, 126663357, 126689371, 127344632, 127344633, 127432415, 127502201, 128627816, 128665766, 129807405, 134355939, 135026299, 135231841, 135631452, 136374189, 137005867, 142360972, 143504354
|
|||
| ChEBI ID |
CHEBI:42843
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Matrix metalloproteinase-8 (MMP-8) | Target Info | Inhibitor | [1] |
| Panther Pathway | Alzheimer disease-presenilin pathway | |||
| Reactome | Collagen degradation | |||
| Degradation of the extracellular matrix | ||||
| Activation of Matrix Metalloproteinases | ||||
| WikiPathways | Activation of Matrix Metalloproteinases | |||
| Matrix Metalloproteinases | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.